Sesame Semaglutide: Personalized GLP-1 Care Options

Last reviewed: May 16, 2026

Last updated: May 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Sesame Semaglutide is a telehealth-based GLP-1 receptor agonist program that enables remote prescribing and medication dispensing. Semaglutide works by activating GLP-1 receptors in the brain and pancreas, slowing gastric emptying and reducing appetite signaling. Clinical trials demonstrate efficacy for weight management and glycemic control, though individual response varies significantly based on genetics and metabolism.

For patients considering GLP-1 therapy, understanding both the mechanism and your individual metabolic context matters. PlexusDx takes a precision-wellness approach: we offer compounded semaglutide options paired with optional genetic testing to reveal predispositions in peptide pathways, helping you and your provider have a more informed conversation about whether this medication aligns with your health goals and biology.

How Semaglutide Functions and Why Response Varies

Semaglutide is a synthetic GLP-1 analog that mimics glucagon-like peptide-1, a naturally occurring hormone regulating blood glucose and satiety. It activates GLP-1 receptors throughout the central nervous system and peripheral tissues, triggering decreased appetite, slowed stomach emptying, and improved insulin secretion. These mechanisms support both weight reduction and blood sugar stabilization.

However, clinical studies show 20–30% of patients experience suboptimal response or higher side effect burden. Genetic variants in GLP1R (the gene encoding the GLP-1 receptor), GIPR, FTO, and MC4R influence medication efficacy and tolerability. Understanding your genetic predispositions in these pathways may help your provider tailor dosing, timing, or consider alternative GLP-1 agents.

Comparing Telehealth GLP-1 Access Models and Treatment Features

Multiple telehealth platforms now offer remote semaglutide prescribing, each with distinct provider interactions, dosing protocols, pharmacy partnerships, and cost structures. Below is a framework to help you evaluate key differences when choosing a GLP-1 program that fits your clinical needs and preferences.

Feature	Typical Telehealth Model	PlexusDx Approach
Medication Source	Brand (Ozempic/Wegovy) or compounded; varies by platform	Licensed 503A compounding pharmacies only; compounded semaglutide, tirzepatide, or microdose protocols
Genetic Testing	Not typically offered; prescribing based on clinical assessment alone	Optional Precision Peptide Genetic Test ($99 add-on, $298 standalone) revealing GLP1R, GIPR, FTO, MC4R predispositions
Provider Consultation	Brief initial visit; ongoing asynchronous messaging	Initial assessment informs baseline; genetic insights support personalized provider discussion
Cost Range	Branded $200–600/mo; compounded $150–400/mo depending on platform	Compounded semaglutide $149/mo; tirzepatide $249/mo; genetic test available as add-on

Patient Selection and Clinical Eligibility Criteria

Semaglutide is indicated for weight management in adults with BMI ≥30 or ≥27 with weight-related comorbidities (hypertension, type 2 diabetes, heart disease), and for glycemic control in type 2 diabetes. Telehealth providers conduct medical history screening: past pancreatitis, personal or family history of medullary thyroid cancer, or pregnancy are contraindications. Kidney and liver function should be assessed, particularly for dose escalation.

Beyond standard inclusion criteria, genetic variants in peptide pathways may inform whether semaglutide alone is optimal or whether combination therapy (like tirzepatide, which targets both GLP-1 and GIP receptors) warrants consideration. A qualified provider integrates medical history, lab markers, and—if available—genetic predisposition data to personalize selection and dosing.

Safety Monitoring, Side Effects, and When to Adjust Treatment

Common semaglutide side effects include nausea, vomiting, constipation, and diarrhea—typically dose-dependent and transient. Serious but rare risks include acute pancreatitis, severe hypoglycemia (if combined with insulin), and gallbladder issues. Telehealth programs should offer clear pathways for reporting adverse events and access to clinical guidance if symptoms persist or worsen. Baseline and periodic labs (fasting glucose, HbA1c, kidney function) support safety monitoring.

Individual tolerability depends partly on genetic predispositions affecting GLP-1 receptor signaling and metabolic response. If you experience significant side effects or plateau in response after 12–16 weeks, discussing dose adjustment, medication timing, or alternative GLP-1 agents with your provider is advisable. Some patients benefit from microdose protocols, which PlexusDx offers at $129/mo, to minimize nausea while optimizing metabolic effect.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test examines four key variants (GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, MC4R rs17782313) that reveal predispositions in GLP-1 and appetite-regulation pathways. This test may help provide context about your individual metabolic architecture and how your body's GLP-1 signaling and energy homeostasis genes influence medication response. Results should be interpreted with a qualified healthcare provider to inform personalized treatment strategy.

The genetic test does not predict exact semaglutide response or guarantee outcomes—genetics is one piece of a complex picture that also includes lifestyle, comorbidities, and prior treatment history. Instead, understanding your genetic predispositions can support a more informed conversation with your provider about starting dose, titration pace, combination therapy options, or alternative agents if semaglutide alone shows suboptimal effect.

Whether you choose Sesame Semaglutide or another telehealth program, adding genetic insights to your clinical evaluation may reduce trial-and-error dosing and help you and your provider identify the most suitable GLP-1 strategy faster. PlexusDx compounded semaglutide ($149/mo) paired with optional genetic testing offers a precision-first alternative for patients seeking personalized, biomarker-informed GLP-1 therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the main difference between Sesame Semaglutide and other telehealth GLP-1 programs?

Sesame Semaglutide is one telehealth platform offering remote prescribing and dispensing of GLP-1 medications. Differences exist in provider access, medication sourcing (brand vs. compounded), cost, and whether genetic or biomarker testing is integrated. Compare programs on pharmacy partnerships, consultation frequency, and available personaliza...

How does semaglutide work mechanically to reduce appetite and weight?

Semaglutide activates GLP-1 receptors in the hypothalamus and brainstem, signaling satiety and reducing hunger hormones. It also slows gastric emptying, prolonging fullness, and increases insulin secretion. These combined effects reduce caloric intake and support sustained weight loss and improved metabolic control over 12–16 weeks.

Can genetic testing help me determine if semaglutide is right for me?

PlexusDx's Precision Peptide Genetic Test reveals predispositions in GLP1R, GIPR, FTO, and MC4R genes that may influence your metabolic response. Genetic results should be discussed with your provider and combined with clinical assessment—they inform personalization but do not diagnose or guarantee treatment success.

What side effects should I expect, and how long do they typically last?

Common side effects include nausea, vomiting, constipation, and diarrhea—usually mild to moderate and transient, resolving within 1–3 weeks at each dose level. Serious risks are rare but include pancreatitis and severe hypoglycemia if combined with insulin. Report persistent symptoms to your provider immediately.

How does PlexusDx compounded semaglutide compare in cost and access to Sesame or other programs?

PlexusDx compounded semaglutide costs $149/mo through licensed 503A pharmacies, comparable to or lower than many telehealth platforms. Add our Precision Peptide Genetic Test ($99 add-on) for personalized genetic insights. Compounded formulations are not FDA-approved branded drugs; discuss sourcing and quality with your provider.

Sesame Semaglutide: Clinical Context and Personalized Treatment Planning